Titan Pharmaceuticals Inc (TTNP) Stock
TTNP is no longer traded. Titan Pharmaceuticals was delisted from the Nasdaq in October 2025.
Prices on this page are historical; the last trade was October 1, 2025 at $4.61.
Titan Pharmaceuticals stock price history
TTNP final trading statistics
- Final close
- $4.61
- Final trading day
- Oct 1, 2025
- Market cap at delisting
- $6.13M
- Shares outstanding
- 1.33M
- Final 52-week range
- $3.03 – $5.76
- Avg. volume (final 3 mo.)
- 101,619
- All-time high (split-adj.)
- $1000000.00 · Sep 2000
- All-time low (split-adj.)
- $3.15 · Jan 2025
- Return since IPO
- -100.0%
- Beta
- 1.38
- Book value / share
- $2.10
- Price / book
- 2.20
Titan Pharmaceuticals annual financials
| Fiscal year | Revenue | Net income | EPS |
|---|---|---|---|
| FY2024 | $0.00 | -$4.7M | -$5.23 |
| FY2023 | $1.0K | -$5.6M | -$2.76 |
| FY2022 | $60.0K | -$10.2M | -$5.74 |
| FY2021 | $1.53M | -$8.1M | -$0.90 |
| FY2020 | $4.84M | -$20.7M | -$5.96 |
Last five fiscal years reported before the delisting; fiscal year ending December. EPS is adjusted (non-GAAP) EPS as reported. Source: company filings via EODHD.
About Titan Pharmaceuticals Inc
As of October 1, 2025, Titan Pharmaceuticals, Inc. was acquired by KE Sdn Bhd, in a reverse merger transaction. Titan Pharmaceuticals, Inc. does not have significant operations. Previously, it was engaged in the development of therapeutics for the treatment of chronic diseases. Titan Pharmaceuticals, Inc. was founded in 1991 and is based in New York, New York.
Titan Pharmaceuticals stock FAQ
What happened to Titan Pharmaceuticals stock?
Titan Pharmaceuticals stock was delisted from the Nasdaq. Its final close was $4.61 on October 1, 2025.
Is TTNP stock still trading?
No. TTNP was delisted from the Nasdaq in October 2025 and no longer trades on a U.S. exchange.
What was the last price of TTNP stock?
TTNP closed at $4.61 on its final trading day, October 1, 2025, for a market value of about $6.13M.
What were Titan Pharmaceuticals's revenue and earnings in its last full fiscal year?
Titan Pharmaceuticals reported revenue of $0.00 and net income of -$4.7M in fiscal 2024, its last full year as a public company.
When did Titan Pharmaceuticals go public?
Titan Pharmaceuticals Inc stock began trading on January 18, 1996.